Skinoren 20% cream for skin lightening, removing melasma, and scars from acne - 30g
40ر.س
Product description
Skinoren Cream 20% with effective Azelaic Acid formula helps in treating acne, reducing inflammation, and exfoliating the skin in addition to lightening spots and scars from pimples with improving skin radiance. From Al-Kaltham Store, the best Saudi care store.
Skinoren Cream 20 specifications:
Classification: Brightening creams
Size: 30 grams – small container suitable for daily routine.
Type: Therapeutic cream containing 20% Azelaic Acid.
Texture: Light cream absorbed into the skin without being overly greasy.
Use / Skin: Suitable for skin prone to acne, dark spots, and uneven skin tone.
Active ingredients and their benefits:
Azelaic Acid (20%):
- Mild exfoliation cleans pores and reduces dead skin cell buildup.
- Has antibacterial and anti-inflammatory properties that help treat acne and black/whiteheads.
- Helps lighten spots caused by previous inflammation (Hyperpigmentation) by inhibiting melanin production.
Method of use:
- Clean your skin well with water or a gentle cleanser, then dry.
- Apply a very thin layer of the cream on affected areas such as the face or back.
- Gently massage the cream until fully absorbed.
- Usually used twice daily (morning and evening), or once initially for sensitive skin.
- In the morning, after absorption, use a sunscreen to protect the skin. (General routine tip)
When to use?:
- Used as part of the daily skincare routine to treat acne, reduce spots caused by it, and unify skin tone.
- Preferably used at night when starting treatment to reduce sun exposure.
Advantages of Skinoren 20:
- Effectively treats acne and black/whiteheads with regular use.
- Exfoliates and smooths the skin by removing dead cells and cleansing pores.
- Helps reduce dark spots and scars from acne with a gentle lightening mechanism.
- Contributes to calming inflammation and redness in treated areas.
- Suitable for most skin types when instructions are followed.
Expected results:
- Gradual improvement in acne and reduction in pimples over weeks.
- Smoother, more radiant skin with decreased pore appearance.
- Clearer lightening and reduction of dark spots from inflammation with regular use.
Suitable for?:
- Those with mild to moderate acne seeking effective treatment.
- Those with uneven skin tone or dark spots after inflammation.
- Suitable for oily and combination skin (according to usage instructions).
- Those looking for a formula that combines acne treatment and spot lightening.
Al-Kaltham recommendations:
- Start with a very small amount (pea-sized) initially to avoid irritation.
- Use a gentle moisturizer after the cream is absorbed to maintain skin hydration. (General routine tip)
- Wear a high SPF sunscreen in the morning to enhance results and prevent pigmentation return. (General advice)
Storage and preservation method:
- Keep the cream in a cool, dry place away from direct sunlight.
- Close the container tightly after each use to maintain the effectiveness of the ingredients.
Warnings:
- For external use only, avoid contact with eyes, mouth, and sensitive areas.
- If redness or severe irritation occurs, stop use temporarily and consult a specialist.
- Some skin may experience slight dryness or peeling, especially initially.
- Avoid use on skin with wounds or severe irritation.
FAQs:
Does it suit sensitive skin?
- It can, but it’s preferable to use it once daily in the evening first, and test a small amount on a small area to ensure skin tolerance.
Does it help remove acne scars?
- Yes, Azelaic Acid gradually lightens and reduces dark spots caused by acne.
When do results appear?
- Improvement may start within 2 to 4 weeks with regular use, while more significant results appear after continued use for several weeks.
Discover a noticeable improvement in acne and dark spots with Skinoren 20% Cream – 30 grams, which combines inflammation treatment, skin exfoliation, and spot lightening in one formula.
Add it now to your daily routine for clearer, more radiant skin with greater confidence every day.



